AzTrials
AzTrials

Brain InjuriesPIHMultiNCT05093777

Program Intensive Habilitation (PIH) for Young Children With Early Brain Damage

A study testing Program Intensified Habilitation and Habilitation as usual in people with Brain Injuries and Cerebral Palsy, run by Sorlandet Hospital HF at 1 site in Norway.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

By longitudinal, prospective research in children with neurodisabilities including severe motor impairments and their parents to explore the beneficial effects of participating in an intensive habilitation program on the child's adaptive functioning and parental empowerment in order to treat and reduce the… Read more about this study

Who is it for?
Ages 2 to 7 years
What is being tested?
Program Intensified Habilitation and Habilitation as usual
Could I receive a placebo?
No, everyone receives an active treatment
How many people
93 participants
Where
1 siteNorway
Study dates
10 Oct 2021to 31 Dec 2025
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 2 to 7 years
  • All sexes
  • No healthy volunteers
  • Child

Who may be able to join

  • age 2 - 6 years at the start of the program
  • a diagnosis of severe cerebral palsy or similar motor disability of non-progressive etiology (GMFCS level IV-V),
  • being able to participate in group sessions
  • having parents who want to take an active part in their child's training
  • least one of the parents must speak fluent Norwegian or English.

Who cannot join

  • children with progressive disorders
  • co-morbidity like autism spectrum disorder, severe visual and hearing impairments or intractable epilepsy that worsen with physical activity.

Trial locations and contacts

1 site in 1 country.

Norway1 site
  • Sørlandet Hospital

    Kristiansand, 4626

Other trials in Norway

About this study

Official title: Evaluation of a Norwegian Model of an Intensive Habilitation Program for Young Children With Early Brain Damage - a Multicentre Randomized Controlled Trial.

By longitudinal, prospective research in children with neurodisabilities including severe motor impairments and their parents to explore the beneficial effects of participating in an intensive habilitation program on the child's adaptive functioning and parental empowerment in order to treat and reduce the consequences of early brain damage.

Read the detailed description

Evidence-based knowledge about the effects of intensive training programs for children with severe early brain damage is limited since research on this topic has methodological weaknesses and shows conflicting results. As intensive training programs require extensive efforts from the child, parents and professionals and represent major costs, the importance of scientifically proven effects is considerable. This research project aims to measure the effects of an intensive habilitation program for young children with severe early brain damage on the child's adaptive, motor, language and social functioning and on parental empowerment, family functioning and stress. In this randomized controlled trial (RCT) 90 children will be divided into an intervention group participating in a Norwegian developed program of intensified habilitation of 12 months duration and a control group, who will receive "services as usual" during the same time period. Between-group analyses will then be performed. Due to a stepped wedge design, the control participants will then be offered training in year two of participation. Within-group analysis of results before and after training will then be performed for all participants. Standardized measures with high responsiveness in documenting intervention effectiveness will be used as primary outcome measures. Intensive training groups will be offered in all Health Regions in Norway and if successful be implemented as standard clinical practice.

Being tested
Program Intensified Habilitation, Habilitation as usual
Keywords
brain injury, cerebral palsy, motor disability, GMFCS level, Pedi-Cat, Family Empowerment scale, Parenting stress index
Medical subject headings
Brain Injuries, Cerebral Palsy, Motor Skills Disorders, Empowerment

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Program Intensified HabilitationOther

    Also called PIH Multi

    The program is based on a holistic and family-centered concept, which acknowledges parents as experts on their child's abilities and needs. The program involves both parents and local professionals, and includes goal setting and goal-directed treatment targeted to the needs of the individual child. The program lasts for about one year and contains three in-patient group sessions over 2 weeks. In between the children are receiving individualized home training programs at home and in pre-school/kindergarten. The children train on a daily basis, both during the inpatient sessions and in the home setting.

  • Habilitation as usualOther

    Also called Control

    When the participants are not joining the study year containing the intervention program, they will be offered habilitation services "as usual" administered by the primary health care services in the local community.

Study groups in NCT05093777
Study groupRoleWhat they receive
Intervention groupExperimentalHalf of the study participants will be randomized to the intensive habilitation program the first year of program. The second year of program this group of participants will be offered habilitation "as usual".
Receives: Other: Program Intensified Habilitation; Other: Habilitation as usual
Control groupOtherHalf of the study participants will be randomized to "treatment as usual" the first year of program, then offered the intensive program during the second year ("stepped wedge design").
Receives: Other: Program Intensified Habilitation; Other: Habilitation as usual

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Change in Pediatric Evaluation of Disability Inventory - Computer Adaptive Test (PEDI-CAT)

    Primary evaluation measure for the child

    Measured: Change from baseline measure at 12 months and after 24 months

  2. Change in Family Empowerment Scale (FES)

    Primary evaluation measure for the parents

    Measured: Change from baseline measure at12 months and after 24 months

Secondary outcomes (2)
  1. Change in Gross motor function measure (GMFM-88)

    Secondary evaluation measure for the child

    Measured: Change from baseline measure at 12 months and after 24 months

  2. Change in Parenting Stress Index (PSI)

    Secondary evaluation measure for the parents

    Measured: Change from baseline measure at 12 months and after 24 months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted26 Oct 2021
  2. Study start10 Oct 2021
  3. Primary completion31 Dec 2025
  4. Study completion31 Dec 2025

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Crossover
Model description
Randomized controlled trial (RCT) with blinded evaluation by independent researchers at baseline, at 12 months and at 24 months. A stepped-wedge design will be applied so that all study participants eventually will be offered the intervention program. Those who are randomized to control group in the first year of study, will be offered intensive training during the second year, and vice versa.
Masking
Single blind
Who is masked
Outcomes assessor
Enrolment
93 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05093777
Sponsor's protocol ID
KlinBeForskSkranes
Acronym
PIHMulti
Status last verified
May 2025
First submitted
28 Sep 2021
Last updated
7 May 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing Program Intensified Habilitation and Habilitation as usual in people with Brain Injuries and Cerebral Palsy, run by Sorlandet Hospital HF at 1 site in Norway.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 5 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 7 May 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Norway. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Change in Pediatric Evaluation of Disability Inventory - Computer Adaptive Test (PEDI-CAT) (time frame: Change from baseline measure at 12 months and after 24 months). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 7 May 2026; AzTrials last refreshed its copy on 2 Nov 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in